Delhivery to Birlasoft: 10 stocks on Nuvama’s radar post Q2. Upside seen up to 57%, downside 9%
Brokerage firm Nuvama has reviewed the Q2 earnings of 10 BSE and NSE-listed companies, assigning Buy, Hold, and Reduce ratings based on their performance and outlook. It maintained Buy on six stocks — Delhivery, Aurobindo Pharma, Devyani International, Crompton Greaves, Minda Corporation, and Indigo Paints. The brokerage issued a Reduce rating on Zydus Lifesciences and Birlasoft, while Hold was recommended for CCL Products and Astral. Here’s a closer look at its analysis: Earnings Radar
Brokerage firm Nuvama has reviewed the Q2 earnings of 10 BSE and NSE-listed companies, assigning Buy, Hold, and Reduce ratings based on their performance and outlook. It maintained Buy on six stocks — Delhivery, Aurobindo Pharma, Devyani International, Crompton Greaves, Minda Corporation, and Indigo Paints. The brokerage issued a Reduce rating on Zydus Lifesciences and Birlasoft, while Hold was recommended for CCL Products and Astral. Here’s a closer look at its analysis: Earnings Radar
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
